uk 68798 has been researched along with Left Ventricular Dysfunction in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 14 (73.68) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Baranowski, B; Bhargava, M; Callahan, TD; Cantillon, DJ; Chung, MK; Dresing, TJ; Hussein, AA; Kanj, M; Koene, RJ; Lindsay, BD; Martin, DO; Menon, V; Niebauer, MJ; Rickard, JW; Saliba, WI; Tarakji, KG; Tchou, PJ; Varma, N; Wazni, OM; Wilkoff, BL | 1 |
| Abildstrøm, SZ; Køber, L; Pedersen, OD; Schmiegelow, MD; Seibæk, M; Torp-Pedersen, C | 1 |
| Saklani, P; Skanes, A | 1 |
| Burchardt, H; Hintze, U; Møller, M; Vach, W; Videbaek, J | 1 |
| Brendorp, B; Elming, H; Køber, L; Torp-Pedersen, C | 1 |
| Kao, W; Kowey, PR; Winkel, E; Yan, GX | 1 |
| Brendorp, B; Elming, H; Jun, L; Køber, L; Torp-Pedersen, C | 2 |
| Brendorp, B; Elming, H; Køber, L; Pedersen, OD; Pehrson, S; Torp-Pedersen, C | 1 |
| Burchardt, H; Gadsbøll, N; Gislason, GH; Køber, L; Quinones, MA; Seibaek, M; Torp-Pedersen, C | 1 |
| Brendorp, B; Burchardt, H; Elming, H; Køber, L; Pedersen, HS; Seibaek, M; Torp-Pedersen, C | 1 |
| Agner, E; Bloch-Thomsen, PE; Camm, AJ; Carlsen, J; Egstrup, K; Køber, L; Marchant, B; Møller, M; Sandøe, E; Torp-Pedersen, C; Videbaek, J | 1 |
| Latini, R | 1 |
| Le Jemtel, TH | 1 |
| Agner, E; Bloch-Thomsen, PE; Carlsen, JE; Egstrup, K; Køber, L; Møller, M; Sandøe, E; Torp-Pedersen, CT; Videbaek, J | 1 |
| Agner, E; Bloch Thomsen, PE; Camm, AJ; Carlsen, J; Egstrup, K; Køber, L; Marchant, B; Møller, M; Sandøe, E; Torp-Pedersen, C; Videbaek, J | 1 |
| Brendorp, B; Elming, H; Jensen, GB; Jun, L; Køber, L; Malik, M; Torp-Pedersen, C | 1 |
| Bagger, H; Keller, N; Køber, L; Marchant, B; Pedersen, OD; Torp-Pedersen, C | 1 |
2 review(s) available for uk 68798 and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Novel anti-arrhythmic medications in the treatment of atrial fibrillation.
Topics: Acetanilides; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Digoxin; Dronedarone; Forecasting; Heart Failure; Humans; Phenethylamines; Piperazines; Pyrrolidines; Ranolazine; Sulfonamides; Technology, Pharmaceutical; Ventricular Dysfunction, Left | 2012 |
Pharmacologic and nonpharmacologic options to maintain sinus rhythm: guideline-based and new approaches.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Catheter Ablation; Flecainide; Heart Rate; Humans; Phenethylamines; Practice Guidelines as Topic; Propafenone; Quinidine; Stroke; Sulfonamides; Ventricular Dysfunction, Left | 2003 |
11 trial(s) available for uk 68798 and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Survival after withdrawal of dofetilide in patients with congestive heart failure and a short baseline QTc interval; a follow-up on the Diamond-CHF QT substudy.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Infant, Newborn; Long QT Syndrome; Male; Middle Aged; Phenethylamines; Proportional Hazards Models; Risk Factors; Sulfonamides; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 2003 |
The prognostic value of QTc interval and QT dispersion following myocardial infarction in patients treated with or without dofetilide.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Denmark; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Humans; Long QT Syndrome; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Phenethylamines; Prognosis; Proportional Hazards Models; Risk Factors; Sulfonamides; Survival Analysis; Systole; Treatment Outcome; Ventricular Dysfunction, Left | 2003 |
Does conversion and prevention of atrial fibrillation enhance survival in patients with left ventricular dysfunction? Evidence from the Danish Investigations of Arrhythmia and Mortality ON Dofetilide/(DIAMOND) study.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Humans; Multicenter Studies as Topic; Phenethylamines; Randomized Controlled Trials as Topic; Retrospective Studies; Sulfonamides; Ventricular Dysfunction, Left | 2003 |
Risk factors and predictors of Torsade de pointes ventricular tachycardia in patients with left ventricular systolic dysfunction receiving Dofetilide.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Output, Low; Cause of Death; Double-Blind Method; Electrocardiography; Female; Forecasting; Heart Arrest; Humans; Male; Middle Aged; Myocardial Infarction; Phenethylamines; Placebos; Potassium Channel Blockers; Risk Factors; Sex Factors; Sulfonamides; Time Factors; Torsades de Pointes; Ventricular Dysfunction, Left | 2007 |
Dofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction: rationale, design, and patient characteristics of the DIAMOND studies. Danish Investigations of Arrhythmia and Mortality ON Dofetilide.
Topics: Aged; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Denmark; Double-Blind Method; Female; Heart Failure; Humans; Male; Myocardial Infarction; Patient Selection; Phenethylamines; Potassium Channel Blockers; Research Design; Risk Factors; Sulfonamides; Ventricular Dysfunction, Left | 1997 |
Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Electrocardiography; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Phenethylamines; Secondary Prevention; Sulfonamides; Survival Analysis; Torsades de Pointes; Ventricular Dysfunction, Left | 1999 |
[Dofetilide in patients with chronic heart failure and left ventricular dysfunction].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Electric Countershock; Female; Follow-Up Studies; Heart Failure; Humans; Male; Phenethylamines; Potassium Channel Blockers; Risk Factors; Sulfonamides; Time Factors; Ventricular Dysfunction, Left | 2000 |
[Dofetilide to patients with heart failure and left ventricular dysfunction].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cause of Death; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Phenethylamines; Sulfonamides; Ventricular Dysfunction, Left | 2000 |
Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Phenethylamines; Sulfonamides; Ventricular Dysfunction, Left | 2000 |
Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chronic Disease; Denmark; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Phenethylamines; Sulfonamides; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
Effect of dofetilide on QT dispersion and the prognostic implications of changes in QT dispersion for patients with congestive heart failure.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Double-Blind Method; Electrocardiography; Endpoint Determination; Female; Follow-Up Studies; Heart Failure; Humans; Long QT Syndrome; Male; Middle Aged; Multivariate Analysis; Observer Variation; Phenethylamines; Potassium Channel Blockers; Prognosis; Reproducibility of Results; Sulfonamides; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
6 other study(ies) available for uk 68798 and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Clinical Outcomes and Characteristics With Dofetilide in Atrial Fibrillation Patients Considered for Implantable Cardioverter-Defibrillator.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Databases, Factual; Defibrillators, Implantable; Electric Countershock; Female; Heart Rate; Humans; Male; Middle Aged; Phenethylamines; Recovery of Function; Recurrence; Retrospective Studies; Stroke Volume; Sulfonamides; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2020 |
Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chi-Square Distribution; Cohort Studies; Denmark; Electrocardiography; Female; Heart Failure; Humans; Incidence; Kaplan-Meier Estimate; Male; Multicenter Studies as Topic; Myocardial Infarction; Phenethylamines; Proportional Hazards Models; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Stroke Volume; Sulfonamides; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2011 |
QT interval dynamics predict mortality in high-risk patients after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Rate; Humans; Male; Multivariate Analysis; Myocardial Infarction; Observer Variation; Phenethylamines; Predictive Value of Tests; Prospective Studies; Risk Factors; Sulfonamides; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
The reliability of echocardiographic left ventricular wall motion index to identify high-risk patients for multicenter studies.
Topics: Anti-Arrhythmia Agents; Denmark; Echocardiography; Humans; Multicenter Studies as Topic; Patient Selection; Phenethylamines; Randomized Controlled Trials as Topic; Reproducibility of Results; Risk Assessment; Sulfonamides; United States; Ventricular Dysfunction, Left | 2006 |
Management of heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Disease; Heart Failure; Humans; Myocardial Revascularization; Phenethylamines; Ramipril; Randomized Controlled Trials as Topic; Sulfonamides; Ventricular Dysfunction, Left | 2000 |
Qt dispersion has no prognostic information for patients with advanced congestive heart failure and reduced left ventricular systolic function.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Denmark; Double-Blind Method; Electrocardiography; Follow-Up Studies; Heart Failure; Humans; Middle Aged; Observer Variation; Phenethylamines; Prognosis; Sulfonamides; Survival Analysis; Ventricular Dysfunction, Left | 2001 |